This study is testing a scoring system that calculates how likely it is that a mass (lump) is malignant (cancerous). Researchers want to find out if the system is better than current clinical practice for predicting malignancy.
The study will enroll patients who have an ovarian cyst or adnexal mass (a lump in the uterus) that requires surgery. A blood sample will be collected from each participant before surgery. Researchers will apply the scoring system to the sample and compare it with the patient’s post-surgery diagnosis (cancerous vs. not cancerous).
Cleo Diagnostics
1000
People
Personen
June 30, 2025
30.6.2025
30.6.2025
30.6.2025
This study is testing a scoring system that calculates how likely it is that a mass (lump) is malignant (cancerous). Researchers want to find out if the system is better than current clinical practice for predicting malignancy.
The study will enroll patients who have an ovarian cyst or adnexal mass (a lump in the uterus) that requires surgery. A blood sample will be collected from each participant before surgery. Researchers will apply the scoring system to the sample and compare it with the patient’s post-surgery diagnosis (cancerous vs. not cancerous).
Female adults who have an ovarian cyst or adnexal mass identified that requires surgery, but who have NOT YET undergone this surgery.
Cleo Diagnostics
1000
People
Personen
June 30, 2025
30.6.2025
30.6.2025
30.6.2025
Females aged 18 and above who:
You will receive $50 compensation for completing the on-site study appointment.